These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis. Gao J, Liu Y, Cui RZ, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM. Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572 [Abstract] [Full Text] [Related]
6. Impact of interleukin 6 promoter polymorphisms (-174 G > C, -572 G > C and -597 G > A) on plasma IL-6 levels and their influence on the development of DVT: a study from India. Sharma A, Singh K, Biswas A, Ranjan R, Kishor K, Pandey H, Kumar R, Mahapatra M, Oldenburg J, Saxena R. Hematology; 2018 Dec; 23(10):833-838. PubMed ID: 29890913 [Abstract] [Full Text] [Related]
8. Single nucleotide polymorphisms in interleukin-6 and their association with venous thromboembolism. Yadav U, Mahemuti A, Hu X, Abudureheman K, Xia Y, Tang B, Upur H. Mol Med Rep; 2015 Jun; 11(6):4664-70. PubMed ID: 25625484 [Abstract] [Full Text] [Related]
10. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans. Koh SJ, Jang Y, Hyun YJ, Park JY, Song YD, Shin KK, Chae JS, Kim BK, Ordovas JM, Lee JH. Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122 [Abstract] [Full Text] [Related]
15. [Interaction of ApoE and LDL-R gene polymorphisms and alcohol drinking and smoking on coronary heart disease]. Wang CH, Zhou X, Zhou GD, Han DF, Zheng F. Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):554-8. PubMed ID: 15144588 [Abstract] [Full Text] [Related]
16. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis. Sie MP, Sayed-Tabatabaei FA, Oei HH, Uitterlinden AG, Pols HA, Hofman A, van Duijn CM, Witteman JC. Arterioscler Thromb Vasc Biol; 2006 Jan 02; 26(1):212-7. PubMed ID: 16269662 [Abstract] [Full Text] [Related]